Researchers Cope With The Increasing Cost Of Convening

While working toward his doctorate in 1973, plant geneticist Peter Gresshoff received an invitation to attend one of the meetings sponsored every summer by the Gordon Research Conferences. For Gresshoff, the mere fact that he was tapped to join the select group of 100 scientists participating in the conference constituted an honor in itself. Substantially more exciting, though, was the prospect of spending a week in close quarters with some of the top researchers in his field. The invitation c

Written byJeff Seiken
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

While working toward his doctorate in 1973, plant geneticist Peter Gresshoff received an invitation to attend one of the meetings sponsored every summer by the Gordon Research Conferences. For Gresshoff, the mere fact that he was tapped to join the select group of 100 scientists participating in the conference constituted an honor in itself. Substantially more exciting, though, was the prospect of spending a week in close quarters with some of the top researchers in his field.

The invitation carried with it a waiver of the registration fee and a small travel stipend. Only one complication remained. Gresshoff, who was studying at the Australian National University in Canberra, had to find a way to pay for his trip to the conference site - in New Hampshire, half a world away.

Gresshoff first turned to his department, which responded with some token support. Left to his own resources to finance the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies